T1	p 94 135	non-insulin dependent diabetes mellitus .
T2	p 255 316	30 non-insulin dependent ( Type II ) diabetic subjects during
T3	p 345 377	( run-in/drug ; placebo/wash-out
T4	p 1224 1235	II diabetes
T5	p 1335 1362	Type II diabetic patients .
T6	i 14 54	angiotensin-converting enzyme inhibitors
T7	i 64 80	antihypertensive
T8	i 150 171	captopril monotherapy
T9	i 227 245	placebo-controlled
T10	i 347 379	run-in/drug ; placebo/wash-out )
T11	i 402 411	Captopril
T12	i 1206 1215	captopril
T13	i 1238 1252	ACE inhibitors
T14	o 175 204	blood pressure and metabolism
T15	o 439 476	systolic and diastolic blood pressure
T16	o 539 602	effects . Mean run-in postprandial blood glucose concentrations
T17	o 765 791	blood kinin concentrations
T18	o 888 1055	. Body mass index , fasting plasma insulin , serum electrolyte pattern , uric acid , white blood count , lipid profile as well as hepatic and renal function parameters